The Effect of a Unique Region of Parvovirus B19 Capsid Protein VP1 on Endothelial Cells

Biomolecules. 2021 Apr 19;11(4):606. doi: 10.3390/biom11040606.

Abstract

Parvovirus B19 (B19V) is a widespread human pathogen possessing a high tropism for erythroid precursor cells. However, the persistence or active replication of B19V in endothelial cells (EC) has been detected in diverse human pathologies. The VP1 unique region (VP1u) of the viral capsid has been reported to act as a major determinant of viral tropism for erythroid precursor cells. Nevertheless, the interaction of VP1u with EC has not been studied. We demonstrate that recombinant VP1u is efficiently internalized by rats' pulmonary trunk blood vessel-derived EC in vitro compared to the human umbilical vein EC line. The exposure to VP1u was not acutely cytotoxic to either human- or rat-derived ECs, but led to the upregulation of cellular stress signaling-related pathways. Our data suggest that high levels of circulating B19V during acute infection can cause endothelial damage, even without active replication or direct internalization into the cells.

Keywords: VP1u; endothelial cells; endothelial stress; parvovirus B19.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Survival
  • Cells, Cultured
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • MAP Kinase Signaling System
  • Parvovirus B19, Human / chemistry*
  • Pulmonary Artery / cytology
  • Rats
  • Rats, Wistar
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / pharmacology
  • Viral Fusion Proteins / chemistry
  • Viral Fusion Proteins / pharmacology*

Substances

  • Recombinant Proteins
  • Viral Fusion Proteins